Stereotaxis, Inc.

For the period ended Jun 30, 2025. Filed Aug 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 13, 2025

STXS$1.14+4.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

	Three Months Ended June 30,		Six Months Ended June 30,
(in thousands, except share and per share amounts)	2025	2024	2025	2024
Revenue:
Systems	$3,038	$240	$5,002	$2,852
Disposables, service and accessories	5,760	4,262	11,268	8,530
Total revenue	8,798	4,502	16,270	11,382
Cost of revenue:
Systems	2,366	187	4,033	2,087
Disposables, service and accessories	1,853	1,002	3,594	2,016
Total cost of revenue	4,219	1,189	7,627	4,103
Gross margin	4,579	3,313	8,643	7,279
Operating expenses:
Research and development	1,777	2,273	4,127	4,516
Sales and marketing	3,269	3,301	6,417	6,304
General and administrative	4,002	3,760	8,497	7,226
Other	(492)	-	(492)	-
Total operating expenses	8,556	9,334	18,549	18,046
Operating loss	(3,977)	(6,021)	(9,906)	(10,767)
Other income (expense)	(1)	(3)	(1)	(3)
Interest income, net	152	191	258	430
Net loss	$(3,826)	$(5,833)	$(9,649)	$(10,340)
Cumulative dividend on convertible preferred stock	(318)	(325)	(632)	(656)
Net loss attributable to common stockholders	$(4,144)	$(6,158)	$(10,281)	$(10,996)
Net loss per share attributable to common stockholders:
Basic	$(0.05)	$(0.07)	$(0.12)	$(0.13)
Diluted	$(0.05)	$(0.07)	$(0.12)	$(0.13)
Weighted average number of common shares and equivalents:
Basic	87,952,086	84,570,738	87,861,231	84,025,335
Diluted	87,952,086	84,570,738	87,861,231	84,025,335

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.